Professional Documents
Culture Documents
Surgical Pathology
56.
Pagets disease; regional carcinoma
57.
Thyroid cancer; age
58.
Breast neoplasms; worst prognosis
59.
Intramuscular myxoma; gelatinous tumor of the thigh
60.
Gynecomastia; Ultrastructural features
61.
Intratubular germ cell neoplasia; placental alkaline phosphatase
62.
Anogenital verrucous carcinoma; description
63.
Renomedullary interstitial cell tumor
64.
Renal artery; Fibromuscular dysplasia
65.
Adenocarcinoma of the urinary bladder; enteric carcinomas
66.
Erythema nodosum; characterization
67.
Contact allergy; Lichenoid interface dermatitis
68.
Progressive multifocal leukoencephalopathy; characteristics
69.
Fibroadenoma of the breast; greatest incidence
70.
Mulitcystic renal dysplasia; renal mass, primitive ducts
71.
Dermatofibrosarcoma protuberans; CD34 positive
72.
Subacute sclerosing panencephalitis; slowly progressive neurodegenerative disease
73.
Osteoblastoma; flat bones
74.
Dermatitis herpetiformis; gluten-sensitive enteropathy
75.
Colon biopsy; labeling of collagen
76.
Pulmonary lesion; lumen of a large airway
77.
Seminoma
78.
Cervical tunnel clusters; dilated endocervical glands
79.
Testicular tumor; 1-year-old
80.
Solitary fibrous tumor of pleura; increased recurrence
81.
Familial adenomatous polyposis syndrome; genetic abnormality
82.
Ground glass hepatocytes; Hepatitis B
83.
Malakoplakia; Escherichia coli
84.
Primary sclerosing cholangitis; primary biliary cirrhosis
85.
Metastatic papillary cancer; good prognosis
86.
Hashimoto's thyroiditis; thyromegaly
87.
Giant cell (temporal) arthritis; Associated findings
88.
Pure hepatic canalicular cholestasis; sepsis
89.
Adenomatoid tumor
90.
Cerebral hematoma metastatic tumor; beta HCG
91.
Kaposi's sarcoma; multiple organs
92.
Biopsy from the great toe; polarized light
93.
Cervical lymph node biopsy; Epstein Barr-virus testing
94.
Enchondroma; low grade central chondrosarcoma
95.
Gastrectomy specimen; ascites and bilateral ovarian masses
96.
Osteoarthritis; femoral head
97.
Yelloe fever; necrosis
98.
Small intestinal tumor; interstitial cells of Cajal
99.
Low grade sil; eventual regression
100.
Gastrointestinal tract dysplasia; unequivocally neoplastic epithelium
101.
Gallbladder; stones
102.
Adenocarcinoma of the lung; predictor of survival
103.
Invasive mammary carcinoma; appearance
104.
Liposarcomas; prognostic indicator
105.
Thymoma; myasthenia gravis
106.
Polymorphous low-grade adenocarcinoma of minor salivary gland; oral cavity
107.
Lobular carcinoma of the breast; Classic-type invasive
108.
Pseudoangiomatous change; breast
109.
Inflammatory breast cancer; dermal lymphatic invasion
110.
Osteoid osteoma; osteoblastoma
111.
Common primary malignant neoplasm; malignant fibrous histiocytoma
112.
Nodular fasciitis; characteristics
113.
Epithelioid sarcoma; positive for cytokeratins
114.
Esophagitis; mid-esophagus biopsy
115.
Crohn's disease; a gastric biopsy
116.
Anti-gliadin antibodies; lymphocytic colitis
117.
118.
119.
120.
121.
122.
123.
124.
125.
126.
127.
Clinical Pathology
Clinical Chemistry
128
Major intracellular cation; K+
129.
Prostate specific antigen; monitoring
130.
Serum osmolality; calculation
131.
Transthyretin; nutritional status
132.
Distal renal tubular acidosis; normal anion gap
133.
Loop diuretics; mechanism
134.
Methanol ingestion; serum osmole gap
135.
LDL cholesterol levels; 160 mg/dL
136.
LDL subclasses; Higher risk
137.
PKU; screening tests
138.
Pituitary gland; prolactin secreting tumor
139.
Method comparison; precision
140.
Fetal fibronectin; negative
141.
Diabetes Mellitus; Fructosamine
142.
Acute leukemia; elevated potassium
143.
Sensitivity of MCV; screen iron deficiency
144.
Distribution of the values: 25th percentile
145.
NT-proBNP: description
146.
Linearity; regression
147.
Cholesterol; maximum bias
148.
CML in blast crisis; glucose
149.
Fasting hypoglycemia; C-peptide
150.
Blunt head trauma; distinguishing fluids
151.
Canavan disease; mutation in aspartoacylase
152.
Fetal fibronectin; preterm labor
153.
Nitric oxide; peroxynitric acid
154.
BNP; congestive heart failure
155.
Drugs of abuse; metabolite of crack cocaine
156.
High-sensitivity C-reactive protein; levels of >15 mg/L indicate active inflammation
157.
Circulating alkaline phosphatase; condition
Hematopathology
159.
Hodgkins disease; lymph node excision
160.
Plasma cell leukemia; peripheral blood smear
161.
Sickle cell disease; hemoglobin electrophoresis patterns
162.
Small megakaryocytes; chronic myelogenous leukemia
163.
Abetalipoproteinemia; peripheral blood smear
164.
Chronic myelomonocytic leukemia; peripheral blood smear
165.
Anemia of chronic disease; lymphadenopathy
166.
Plasma cell myeloma; WHO
167.
Severe neutropenia in the neonatal age; bacterial sepsis
168.
chronic myelogenous leukemia; absolute basophilia
169.
Chloroacetate esterase; myeloid sarcoma
170.
Beta-thalassemia trait; hemoglobin A2
171.
Hyperdiploid karyotype; peripheral blood slide
172.
Toxoplasmosis; lymph node
173.
174.
175.
176.
177.
178.
179.
180.
181.
182.
183.
184.
185.
186.
187.
188.
189.
190.
191.
192.
193.
194.
195.
196.
197.
198.
199.
200.
201.
202.
203.
Microbiology
204.
Coxsackieviruses; persistent viral infection
205.
Susceptibility testing; disk selection
206.
Listeria; gram positive bacillus
207.
Staphylococcus aureus; coagulase test
208.
Staphylococcus aureus; colony characterizations
209.
Prevotella intermedi; pleural fluid
210.
Granulomatous dermatitis; microscopic appearance
211.
Anaplasma phagocytophilia; human granulocytic ehrilichiosis (HE)
212.
Rickettsia rickettssii; camping trip
213.
Staphylococcus aureus; mec A gene
214.
FTA-ABS test; Treponema pallidum
215.
Streptococcus pyogenes; blood culture slide
216.
Enterococcus faecalis; blood culture slide
217.
Stool assay; post-antibiotic diarrhea
218.
Ascaris lumbricoides; cysticercosis
219.
Highly pathogenic; non immunocompromised human hosts
220.
Bartonella henselae; cat scratch disease
221.
Pneumocococus; erythromycin resistance
222.
Mycobacterium tuberculosis; nitrate positive
223.
Trichophyton species; infections of hair follicles
224.
Penicillin resistant S. pneumoniae; oxacillin disk
225.
Parvovirus B19; "fifth's" disease
226.
Clostridium difficile toxin assays; hospitalized adult patient
227.
Neonate sepsis; blood culture
228.
Bovine spongioform encephalopathy; Creutzfeldt-Jacob disease
229.
Epstein-Barr virus infection; post-transplant lymphoproliferative disorders
230.
Malarial infection; red blood cell morphologic alterations
231.
Colonic spirochetosis; identified histologically
232.
Toxoplasma encephalitis; multifocal necrotizing lesions
233.
234.
235.
236.
237.
238.
239.
240.
Transfusion Medicine
241.
Irradiation of Blood; CMV
242.
Red blood cell preservative or; approved shelf life
243.
Plasmapheresis for TTP; replacement solution
244.
Cord red blood cells; Lea
245.
Transfusion records; FDA
246.
Dosage; Kidd
247.
Gamma irradiation; GVHD
248.
Cold-reactive agglutinin; anti-I
249.
TRALI; pulmonary edema
250.
Autologous donor; Requirements
251.
Plasmodium vivax; Fy(a-b-)
252.
Transfusion reaction; additional transfusions
253.
Platelet pheresis donors; Requirement
254.
HLA-identical match; siblings
255.
Enzyme treatment; S antigen
256.
Donor reaction; treatment is
257.
Blood preservation; pH
258.
Massively transfused patient; bleeding
259.
HIV infections; EIA-detectable antibodies
260.
Critical titer of anti-D; amniocentesis
261.
TRALI; anti-leukocyte antibodies
262.
Leukocyte-reduced Red Blood Cells; cytomegalovirus
263.
Infectious mononucleosis; anti-I
264.
Massive transfusion; platelet transfusion
265.
Donor Collection; additional blood
266.
Chronic Transfusion; chelators
267.
Anti-K and anti-Fya; Enzyme techniques
268.
Malaria; Haiti
269.
Antithetical platelet antigens; GPIIIa
270.
Rh null phenotype; stomatocytes
271.
Plasma products; expiration
272.
Bleeding complications; central line placement
273.
Anti-M; glycophorin A
274.
Apheresis catheter placement; patient management
275.
Cryoprecipitate; minimum factor
276.
Mislabeled Specimen; RBC unit issue
277.
Lewis antibody; first pregnancy
278.
Granulocyte transfusion; graft versus host disease
279.
T cell depletion; engraftment failure
280.
Blood component preparation; order of steps
Special Topics
Immunopathology
281.
Paroxysmal nocturnal hemoglobinuria; Ham's test
282.
Immunofluorescence Lupus Band Test; skin
283.
IgA molecules; placenta
284.
IgA deficiency; Caucasians
285.
Severe renal pathology; autoantibody
286.
Silicone breast implants; autoimmune disease
287.
Bence Jones protein; chemical structure
288.
Anti-mitochondrial antibody; symptoms
289.
Acute-phase reaction; indicator
290.
291.
292.
293.
294.
295.
296.
297.
298.
299.
Laboratory Administration
300.
Maslow; highest level
301.
Motivation technique; empowerment
302.
Accrediting organization; JCAHO
303.
CLIA waived tests; FDA review
304.
Internet connection; T1
305.
Archive hypertext documents; CD-RW
306.
Retention of laboratory reports; time requirements
307.
Current Procedural Terminology; code for a medical procedure or service
308.
Flow chart; symbol
309.
Medicare Part B reimbursement; pathologist services
310.
Specimen referral; illegal
311.
Laboratory employees; Hepatitis B vaccine
312.
majority of tests; type of laboratory
313.
Medicare; billing notification
Special Techniques
314.
Flow cytometry; lymphocyte scatter
315.
HLA type; disease association
316.
Angioimmunoblastic lymphadenopathy; gene rearrangements
317.
Mantle cell lymphoma; phenotypic marker
318.
Acute myelogenous leukemia; retinoic acid therapy
319.
Anaplastic large cell lymphoma; CD30 positivity and t(2;5) translocation
320.
Synovial sarcoma; t(X;18)(p11;q11)
321.
Fragile X syndrome; trinucleotide expansion disease
322.
Hairy cell leukemia; CD11c, CD22, CD25, and CD103
323.
Myelodysplastic syndromes; chromosome changes
324.
Multiple Endocrine Neoplasia type 2; RET gene
325.
Inherited thrombophilia; factor V Leiden mutation